Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 6
2004 5
2005 8
2006 8
2007 4
2008 2
2009 3
2010 5
2011 2
2012 6
2013 5
2014 6
2015 6
2016 6
2017 8
2018 11
2019 14
2020 18
2021 21
2022 25
2023 29
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

185 results

Results by year

Filters applied: . Clear all
Page 1
Phosphoproteomic Analysis Identified Mutual Phosphorylation of FAK and Src as a Mechanism of Osimertinib Resistance in EGFR-Mutant Lung Cancer.
Tozuka T, Noro R, Yoshida K, Takahashi S, Hirao M, Matsuda K, Kato Y, Nakamichi S, Takeuchi S, Matsumoto M, Miyanaga A, Kunugi S, Honda K, Adachi J, Seike M. Tozuka T, et al. Among authors: seike m. JTO Clin Res Rep. 2024 Mar 21;5(4):100668. doi: 10.1016/j.jtocrr.2024.100668. eCollection 2024 Apr. JTO Clin Res Rep. 2024. PMID: 38646155 Free PMC article.
Interstitial lung disease with prolonged fever that occurred during long-term administration of olaparib in a 74-year-old ovarian cancer patient: Radiological features and considerations for preventing delayed diagnosis.
Saito Y, Yamaguchi R, Suzuki T, Sato J, Nishijima N, Saito S, Aoyama J, Taniuchi N, Seike M, Katsumata N. Saito Y, et al. Among authors: seike m. Radiol Case Rep. 2024 Mar 8;19(6):2100-2105. doi: 10.1016/j.radcr.2024.02.064. eCollection 2024 Jun. Radiol Case Rep. 2024. PMID: 38645548 Free PMC article.
Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer.
Tozuka T, Noro R, Mizutani H, Kurimoto F, Hakozaki T, Hisakane K, Naito T, Takahashi S, Taniuchi N, Yajima C, Hosomi Y, Hirose T, Minegishi Y, Okano T, Kamio K, Yamaguchi T, Seike M; East Japan Chesters Group. Tozuka T, et al. Among authors: seike m. Lung Cancer. 2024 Mar 24;191:107540. doi: 10.1016/j.lungcan.2024.107540. Online ahead of print. Lung Cancer. 2024. PMID: 38614069
Clinical course of COPD patients with exercise-induced elevation of pulmonary artery pressure or less severe pulmonary hypertension presenting with respiratory symptoms and the impact of bosentan intervention-prospective, single-center, randomized, parallel-group study.
Kashiwada T, Tanaka Y, Tanaka T, Okano T, Saito Y, Seike M, Hino M, Kimura H, Gemma A. Kashiwada T, et al. Among authors: seike m. BMC Pulm Med. 2024 Feb 17;24(1):90. doi: 10.1186/s12890-024-02895-0. BMC Pulm Med. 2024. PMID: 38368315 Free PMC article. Clinical Trial.
Smoking-Related Interstitial Fibrosis and Smoker's Macrophages.
Taniuchi N, Saito Y, Motoda N, Seike M. Taniuchi N, et al. Among authors: seike m. J Nippon Med Sch. 2024 Mar 9;91(1):20-27. doi: 10.1272/jnms.JNMS.2024_91-113. Epub 2024 Jan 16. J Nippon Med Sch. 2024. PMID: 38233126 Free article.
A phase II study of atezolizumab with bevacizumab, carboplatin, and paclitaxel for patients with EGFR-mutated NSCLC after TKI treatment failure (NEJ043 study).
Watanabe S, Furuya N, Nakamura A, Shiihara J, Nakachi I, Tanaka H, Nakao M, Minato K, Seike M, Sasaki S, Kisohara A, Takeuchi S, Honda R, Takamura K, Kagamu H, Yoshimura K, Kobayashi K, Kikuchi T. Watanabe S, et al. Among authors: seike m. Eur J Cancer. 2024 Jan;197:113469. doi: 10.1016/j.ejca.2023.113469. Epub 2023 Dec 2. Eur J Cancer. 2024. PMID: 38061214 Clinical Trial.
Predictive Impact of Diffuse Positivity for TTF-1 Expression in Patients Treated With Platinum-Doublet Chemotherapy Plus Immune Checkpoint Inhibitors for Advanced Nonsquamous NSCLC.
Terashima Y, Matsumoto M, Iida H, Takashima S, Fukuizumi A, Takeuchi S, Miyanaga A, Terasaki Y, Kasahara K, Seike M. Terashima Y, et al. Among authors: seike m. JTO Clin Res Rep. 2023 Sep 21;4(11):100578. doi: 10.1016/j.jtocrr.2023.100578. eCollection 2023 Nov. JTO Clin Res Rep. 2023. PMID: 37885809 Free PMC article.
185 results